clinical trial · NCT05285527
MiSight 1 Day Safety Post-Approval Study
CooperVision, Inc.·N/A·active not recruiting·n = 2,400
MyopiaMiSight 1 Day
brief summary
The purpose of this post-approval study is to confirm the safety of daily disposable soft contact lens wear among the intended patient population for the MiSight 1 Day lens in the US.
started
Aug 15, 2022
primary completion
Mar 2, 2030
completion
Jun 30, 2030
last updated
Jul 8, 2026
detailed description
This prospective post-approval study of safety in a US study population is to confirm the safety of MiSight 1 day lenses. Consecutive subjects receiving the MiSight 1 Day lens, who meet the inclusion criteria, will be prospectively offered to participate in the study. Additionally, safety data from the MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms (PAS001) will be used to supplement this safety study.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol